切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2013, Vol. 09 ›› Issue (06) : 730 -734. doi: 10.3877/cma.j.issn.1673-5250.2013.06.003

所属专题: 文献

论著

REDD1蛋白在子痫前期患者胎盘的表达及意义
胡雅毅1,*,*(), 魏薇1   
  1. 1. 610041 四川成都,四川大学华西第二医院妇产科
  • 收稿日期:2013-10-05 修回日期:2013-11-17 出版日期:2013-12-01
  • 通信作者: 胡雅毅

REDD1 Expression in Placenta in Pre-eclampsia Patients

Ya-yi HU1(), Wei WEI1   

  1. 1. Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province , China
  • Received:2013-10-05 Revised:2013-11-17 Published:2013-12-01
  • Corresponding author: Ya-yi HU
  • About author:
    (Corresponding author : HU Ya-yi,Email : )
引用本文:

胡雅毅, 魏薇. REDD1蛋白在子痫前期患者胎盘的表达及意义[J]. 中华妇幼临床医学杂志(电子版), 2013, 09(06): 730-734.

Ya-yi HU, Wei WEI. REDD1 Expression in Placenta in Pre-eclampsia Patients[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2013, 09(06): 730-734.

目的

探讨子痫前期患者胎盘中REDD1蛋白的表达情况。

方法

选择2011年12月至2012年4月四川大学华西第二医院收治的确诊为子痫前期,年龄为(31. 4±1. 4)岁的单胎妊娠孕妇29例为研究对象。按照妊娠中子痫前期发生的时间,将其分为早发型子痫前期组(n= 15)和晚发型子痫前期组(n=14)。同时按入院顺序号随机选择孕期在本院产前检查,年龄为(32.0±2.8)岁的单胎妊娠健康孕妇20例纳入对照组(本研究遵循的程序符合四川大学华西第二医院人体试验委员会制定的伦理学标准,得到该委员会批准,分组征得受试对象知情同意,并与之签署临床研究知情同意书)。采用SP免疫组织化学染色技术,Western bloting杂交及实时荧光定量PCR检测受试者REDD1蛋白及其mRNA在胎盘组织中的表达,并采用相关统计学方法分析早发型子痫前期组、晚发型子痫前期组及对照组胎盘组织中REDD1蛋白表达差异。早发型子痫前期组及晚发型子痫前期组患者的一般临床资料(年龄、孕周及产次)分别与对照组比较,差异均无统计学意义(P>0.05)。

结果

REDD1蛋白表达于胎盘滋养细胞的细胞质。早发型子痫前期组及晚发型子痫前期组胎盘组织中REDD1蛋白水平均较对照组显著增高,差异有统计学意义(P< 0.05)。早发型子痫前期组REDD1 mRNA表达水平较对照组明显增高,差异亦有统计学意义(P<0.05);但晚发型子痫前期组与对照组比较,差异无统计学意义(P>0.05)。

结论

REDD1蛋白可能在子痫前期发病机制中起重要作用。

Objective

To study the expression of REDD1 in women with pre-eclampsia (PE).

Methods

This study involved normal outcome pregnancies women with an average age of (32. 0 ± 2. 8)years old (n = 20, gestational age >37 weeks) and PE group with an average age of (31. 4 ± 1. 4) years old. According to the time of PE onset, pregnancies women with PE were divided into early-onset PE group (n=15,gestational age:24-33 weeks) and late-onset PE group(n= 14, gestational age:34-39 weeks). All of subjects were included from December 2011 to April 2012 in West China Second University Hospital, Sichuan University. The study protocol was approved by the Ethical Review Board of Investigation in Human Beings of West China Second University Hospital, Sichuan University. Informed consent was obtained from each participating patient. In experiments,REDD1 protein in the placenta was examined and located by SP immunohistochemistry, furthermore, REDD1 protein was ensured by Western blot. Additionally, REDD1 mRNA expression level was determined by relative quantitative real time fluorescence PCR. REDD1 protein and it's mRNA expression levels were compared between early-onset PE group,late-onset PE group and control group by advisable statistical methods. There had no significance difference in three groups among basic clinical parameters including age, gestational age and parity(P>0. 05).

Results

REDD1 protein was predominantly observed in the cytoplasm of villous cytotrophoblast and trophoblast but rarely in fetoplacental vascular. Compared with control group: Expression of REDD1 protein more significantly elevated in both early-onset PE group and late-onset PE group (P<0. 05). Moreover, REDD1 mRNA level also had significantly increased in early-onset PE group than that in control group (P<0. 05); but there had no significance between REDD1 mRNA in late-onset PE group and that in control group.

Conclusions

REDD1 was expressed universally in placental villi and had functions in development of placenta. Increased REDD1 protein may play an important role in pathogenesis of preeclampsia.

表1 两组一般临床资料比较(±s)
Table 1 Comparison of general clinic data among groups(±s)
图1 REDD1蛋白在胎盘组织中的定位(图1A:子痫前期组胎盘组织;图1B:对照组胎盘组织;图1C:阴性对照)(SP免疫组化染色,×400)
Figure 1 Localization of REDD1 protein in placenta(Figure 1A:PE group; Figure 1B: control group; Figure 1C: negative control group) (SP stain, ×400)
表2 3组胎盘组织REDD1 mRNA及其蛋白表达比较(±s)
Table 2 Comparison of the expression of REDD1 mRNA and REDD1protein in placenta tissues among three groups (±s)
图2 REDD1的实时荧光PCR熔解曲线分析
Figure 2 Melting curve analysis of REDD1 real time PCR
图3 REDD1的Western blot凝胶电泳结果(N:对照组;early-PE:早发子痫前期组;late-PE:晚发子痫前期组)
Figure 3 Results of REDD1 by Western blot(N: control group; early-PE: early-PE group ; late-PE : late-PE group)
1
Chang B, Liu G, Yang G, et al. REDD1 is required for RAS-mediated transformation of human ovarian epithelial cells[J]. Cell Cycle,2009,8(5) :780-786.
2
Dayan F, Mazure NM, Brahimi-Horn MC, et al. A dialogue between the hypoxia-inducible factor and the tumor microenvironment[J]. Cancer Microenviron, 2008,1(1) : 53-68.
3
Schneider A, Younis RH, Gutkind JS. Hypoxia-induced energy stress inhibits the mTOR pathway by activating an AMPK/ REDD1 signaling axis in head and neck squamous cell carcinoma [J]. Neoplasia,2008,10(11): 1295-1302.
4
Redman CW, Sargent IL. Placental stress and preeclampsia : A revised view[J]. Placenta,2009,30(1) : S38-S42.
5
Schwarzer R, Tondera D, Arnold W, et al. REDD1 integrates hypoxia mediated survival signaling downstream of phosphatidylinositol 3 kinase [J]. Oncogene, 2005,24 (7) : 1138-1142.
6
Adams JM, Difazio LT, Rolandelli RH, et al. HIF-1: A key mediator in hypoxia[J]. Acta Physiol Hung,2009,96(1) : 19-28.
7
DeYoung MP, Horak P, Sofer A, et al. Hypoxia regulates TSC1/ 2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling[J]. Genes Dev, 2008,22(2) :239-251.
8
Ietta F, Wu YH, Winter J, et al. Dynamic HIF1A regulation during human placental development[J]. Biol Reprod,2006,75(1): 112-121.
9
Shoshani T, Faerman A, Mett I,et al. Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis[J]. Mol Cell Biol, 2002,22(7) :2283-2293.
10
Rajakumar A, Kerry A, Whitelock LA, et al. Selective overexpression of the hypoxia inducible transcription factor, HIF-2,in placentas from women with preeclampsia [J]. Biol Reprod, 2001,64(2):499-506.
[1] 魏宇婷, 罗红. 超声弹性成像评价胎儿生长受限的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 256-260.
[2] 冯丹艳, 曹晓辉, 史玉霞. 血清脂联素与胎盘亮氨酸氨肽酶对妊娠期糖尿病患者妊娠结局的影响[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 302-308.
[3] 匡德凤, 李志国, 华绍芳, 薛凤霞. 高脂诱导孕鼠血清及胎盘组织脂肪酸结合蛋白-4及相关脂蛋白水平变化及其意义[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 338-344.
[4] 韦先梅, 韩毓, 蒋英彩. 敲减circSERPINE2通过靶向调控miR-34a-5p表达抑制滋养层细胞增殖、迁移和侵袭[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 193-201.
[5] 吴晓翔, 杨波, 李景漩, 张凤玲, 郭桂辉, 郑少培. 脐动脉超声检查联合NLR、sFlt-1/PLGF对妊娠高血压综合征患者不良妊娠结局的预测价值[J]. 中华临床医师杂志(电子版), 2023, 17(03): 266-271.
[6] 郭志荣, 马京梅. 胎盘植入性疾病的风险评估和治疗策略[J]. 中华产科急救电子杂志, 2023, 12(03): 151-154.
[7] 张丽姿, 陈敦金. 胎盘植入性疾病的不良结局及远期影响[J]. 中华产科急救电子杂志, 2023, 12(03): 155-158.
[8] 古士锋, 张丽姿, 梁景英, 杜丽丽, 孙雯, 陈敦金. 2011-2021年我国胎盘植入性疾病研究热点:基于CiteSpace可视化分析[J]. 中华产科急救电子杂志, 2023, 12(03): 159-166.
[9] 岳永飞, 朱利平, 王晓艳. 磁共振成像技术在预测胎盘植入性疾病患者剖宫产术中出血量的研究[J]. 中华产科急救电子杂志, 2023, 12(03): 167-172.
[10] 王永, 李霞林, 杨蓉, 潘康妮, 余琳, 王伟伟, 孙雯, 陈敦金. 胎盘植入合并严重产后出血输血方案的研究[J]. 中华产科急救电子杂志, 2023, 12(03): 173-179.
[11] 吴文诗, 魏宋荃, 李桂民, 郑晓芳, 孙雯, 陈敦金, 余琳. 胎盘植入性疾病患者行子宫部分切除术后再次妊娠的临床研究[J]. 中华产科急救电子杂志, 2023, 12(03): 180-186.
[12] 陆晓勤, 刘先保, 龙尚乾, 宋可欣, 邓艳红, 张春芳. 不同程度胎盘植入患者剖宫产的麻醉决策及母婴结局[J]. 中华产科急救电子杂志, 2023, 12(03): 187-192.
[13] 中国医师协会妇产科分会母胎医学专委会, 中华医学会围产医学分会重症学组. 预防性介入治疗在胎盘植入性疾病的应用专家共识(2023)[J]. 中华产科急救电子杂志, 2023, 12(03): 133-140.
[14] 陈颖, 曾万江. 病理组织学诊断在胎盘植入性疾病中的作用和意义[J]. 中华产科急救电子杂志, 2023, 12(03): 143-146.
[15] 赵先兰, 周艳. 胎盘植入性疾病出血血管介入治疗策略[J]. 中华产科急救电子杂志, 2023, 12(03): 147-150.
阅读次数
全文


摘要